Cognition Therapeutics (CGTX) Stock Chart & Stock Price History $1.26 +0.01 (+0.80%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.25 -0.01 (-0.95%) As of 05/22/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cognition Therapeutics Stock Price Performance The Cognition Therapeutics (CGTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 324.39%, with a year-to-date return of -6.67%. In the past month, the stock has decreased 1.56%, reflecting recent market activity. As of the latest close, Cognition Therapeutics traded at $1.26 with a market cap of $112.77 million and volume of 525,913 shares. Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+13.51%1 Month Performance-1.56%3 Month Performance+21.15%Year-To-Date Performance-6.67%1 Year Performance+324.39% CGTX Stock Chart for Sunday, May, 24, 2026 CGTX Chart by TradingView Cognition Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2026$1.25$1.26+0.80%$1.26$1.22525,913 shs$112.77 million05/21/2026$1.29$1.25-3.10%$1.28$1.22891,040 shs$111.88 million05/20/2026$1.11$1.29+16.22%$1.30$1.091.61 million shs$115.46 million05/19/2026$1.09$1.11+1.83%$1.14$1.05560,052 shs$99.34 million05/18/2026$1.14$1.09-4.39%$1.15$1.07968,927 shs$97.56 million05/15/2026$1.20$1.14-5.00%$1.20$1.11763,609 shs$102.03 million05/14/2026$1.20$1.20$1.24$1.13849,791 shs$107.40 million05/13/2026$1.18$1.20+1.69%$1.22$1.17794,008 shs$107.23 million05/12/2026$1.18$1.18$1.19$1.13676,616 shs$105.43 million05/11/2026$1.21$1.18-2.48%$1.25$1.16953,778 shs$105.43 million Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2026$1.16$1.21+4.31%$1.23$1.15693,484 shs$103.65 million05/07/2026$1.23$1.16-5.69%$1.26$1.13926,408 shs$103.65 million05/06/2026$1.24$1.23-0.81%$1.27$1.17857,149 shs$109.90 million05/05/2026N/A$1.24$1.30$1.21685,270 shs$110.79 million04/30/2026$1.18$1.26+6.78%$1.27$1.18620,755 shs$112.58 million04/29/2026$1.28$1.18-7.81%$1.28$1.16967,755 shs$105.43 million04/28/2026$1.29$1.28-0.39%$1.31$1.25508,483 shs$114.37 million04/27/2026$1.28$1.29+0.39%$1.36$1.241.07 million shs$114.82 million04/24/2026$1.26$1.28+1.59%$1.31$1.24691,227 shs$114.37 million04/23/2026$1.29$1.26-2.33%$1.33$1.241.25 million shs$112.58 million Related Companies AgomAb Therapeutics Stock Chart Lexeo Therapeutics Stock Chart Monopar Therapeutics Stock Chart Benitec Biopharma Stock Chart C4 Therapeutics Stock Chart Cellectis Stock Chart Opus Genetics Stock Chart Enanta Pharmaceuticals Stock Chart Greenwich LifeSciences Stock Chart Larimar Therapeutics Stock Chart Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGTX) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredGold hit $4,500 - but these miners haven't caught up yet$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
